Xiaopeng He
Angel Investor @ Delian Capital
Guangzhou, China
Xiaopeng He is a Series A investor at Delian Capital in Guangzhou focused on Health Care and Biotechnology. He Xiaopeng is the Co-Founder and Chief Product Officer of UCWeb Inc. and is in charge of the overall product design and R&D of the company. He has extensive working experience in foreign owned enterprises and as an entrepreneur. He and Liang Jie jointly founded UCWeb in 2004. Under their leadership, UCWeb’s product and technology hasgained significant market share in China. In 2011, He and his team developed proprietary U3 engine, being the first proprietary technology developed in the mobile browser industry in China.Before joining UCWeb, He worked as Technology Manager, Testing Manager, and Project Manager at AsiaInfo Technologies (China) Co., Ltd.He received his Bachelor’s degree in Computer Science from South China University of Technology in 1999.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Xiaopeng He invests in
Stages Xiaopeng He invests in
Countries Xiaopeng He invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Series B
- $29M–$585M
Investment Focus
Industry
- Health Care 2 (33%)
- Biotechnology 2 (33%)
- Autonomous Vehicles 2 (33%)
- Computer 1 (17%)
- Software 1 (17%)
Stage
- Series A 3 (50%)
- Series B 2 (33%)
- Series C 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| XinjingZhiyuan is an immune cell therapy company focusing on solid tumors. | $28.7M / Series B / Jan 26, 2026 | ||
Zhishan Weixin Biotechnology
|
Zhishan Weixin Biotechnology integrates gene-drug research and development to treat genetic and neurodegenerative diseases. The company focuses on the research and development and subversive production of rAAV gene drugs. Zhishan Weixin's therapeutic areas cover blood diseases, rare diseases, and other disease areas. | Series A / Feb 09, 2021 | |
| Xiaopeng Motors is an electric vehicle and technology company that designs and manufactures intelligent mobility solutions. | $400M / Series C / Nov 12, 2019 | ||
| WeRide develops Level 4 autonomous driving technologies and provides products such as Robotaxi, Robobus, Robovan, Robosweeper, and ADAS systems. The company focuses on applications in ride-hailing, on-demand transport, urban logistics, and sanitation services. It conducts research, testing, and operations in various urban environments and workswith original equipment manufacturers and automotive suppliers to support deployment of autonomous systems. | Series A / Oct 31, 2018 | ||
| Xiaopeng Motors is an electric vehicle and technology company that designs and manufactures intelligent mobility solutions. | $584.5M / Series B / Aug 02, 2018 | ||
| Xiaopeng Motors is an electric vehicle and technology company that designs and manufactures intelligent mobility solutions. | Series A / Dec 15, 2017 |
Co-Investors
About Delian Capital
Founded in 2011, Delian Capital specializes in the field of tech-driven industry such as high-end manufacturing, cutting-edge technologies, and healthcare. Their investments range from robotics, Smart manufacturing Semiconductor, AI, big data, enterpriseservices, healthcare, etc.Examples of their investment portfolio: YueBoo、Hunan zhongli、Esafenet、Venus MedTech、MicuRx、Rokae、 IMI、12 Sigma Technologies.
Delian Capital Contacts
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Xiaopeng He invest in?
Xiaopeng He invests primarily in Health Care, Biotechnology and Autonomous Vehicles startups, most often at Series A and Series B stage. Most of the 6 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Xiaopeng He's check size?
Xiaopeng He typically joins rounds of $29M–$585M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Xiaopeng He participates in.
How do I contact Xiaopeng He?
Public channels for Xiaopeng He include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Xiaopeng He last invest?
The most recent investment recorded for Xiaopeng He closed in Jan 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
